Director, Medical Affairs Oncology, Strategic Evidence & Collaborations (SEC)

MA/MS and 10+years of experience in Medical Affairs or success in a similar role outside of the biotech/pharmaceutical industry OR

BA/BS and 12+years of experience in Medical Affairs or success in a similar role outside of the biotech/pharmaceutical industry

10+ years of experience in Medical Affairs or success in a similar role outside of the biotech/pharmaceutical industry.

Experience specific to oncology

and query key findings from study data and publications.

of and adhere to regulatory and legal (Business Conduct) requirements for clinical trials and related Medical Affairs activities; thorough knowledge of FDA regulations, ICH guidelines, and GCPs governing the conduct of clinical trials is preferred

Bay Area: $243,100.00 - $314,600.00.

Other US Locations: $221,000.00 - $286,000.00.

Gilead considers a variety of factors when determining base compensation, including experience, qualifications, and geographic location. These considerations mean actual compensation will vary. This position may also be eligible for a discretionary annual bonus, discretionary stock-based long-term incentives (eligibility may vary based on role), paid time off, and a benefits package. Benefits include company-sponsored medical, dental, vision, and life insurance plans*.

* Eligible employees may participate in benefit plans, subject to the terms and conditions of the applicable plans.

For jobs in the United States:

We have an exciting opportunity within US Medical Affairs for

, Medical Affairs Oncology, Strategic Evidence & Collaborations (SEC)

Reporting to the Senior Director and Head of Strategic Evidence & Collaborations, US Medical Affairs (USMA), the core efforts of this role is to be responsible for co-developing the US Medical Affairs strategy for US Medical Affairs congress plans in collaboration with the COE (Congress Center of Excellence) and the USMA Strategy and Field Based Medical Teams.

The key functions of this role will be to represent and consider the healthcare environment of the US with internal and external stakeholders involved in cancer therapies across approved and pipeline molecules and indications, including the Global Medical Affairs team, US Medical Access and Quality team, Scientific Communications/Publications, Medical Affairs Outcomes Research, Commercial Strategy, Marketing, Value and Market Access,  Clinical Research/Development, US Public Affairs, US Government Affairs ,Patient Engagement, Business Conduct (Legal), and the field-based US Medical Science Liaisons.

As an integral part of the USMA Oncology team, and in close collaboration with Oncology medical directors, Field Medical., Global Medical

Patient Access and Quality, and cross-functional partners, this role will establish and execute an overarching strategy for evidence generation across various tumor types in the US,